March 28, 2023
The University of Cincinnati's Jeffrey Strawn was featured in a PsyCom Pro article highlighting new research that found ADHD treatments may also help executive function deficits.
March 28, 2023
Treatment of the first patient in a clinical trial of FLASH proton therapy for cancers in the bones of the chest has been completed at the Cincinnati Children’s/University of Cincinnati Medical Center Proton Therapy Center.
March 28, 2023
Researchers led by the University of Cincinnati's Nalinikanth Kotagiri, PhD, have published new research showing proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.
March 27, 2023
NPR's Marketplace wanted to know what would happen if some or all student loans were forgiven and turned to experts, including University of Cincinnati economist Michael Jones.
March 24, 2023
Walking with Bubbles, a one-woman musical opening March 31 at the AMT Theater in New York, is the culmination of years of work by talented artists. There’s something special about this production, though: it’s written, directed, designed by and starring UC College-Conservatory of Music (CCM) alumni and faculty!
March 23, 2023
The University of Cincinnati's Erich J. Boomgarden, MD, provided expert analysis of a new Food and Drug Administration policy that will require health care providers to tell women if they have dense breast tissue, a change that could save lives.
March 22, 2023
As UC and P&G build on their partnership, they have renamed and celebrated the P&G Digital Accelerator @ The University of Cincinnati.
March 22, 2023
Local 12 highlighted the University of Cincinnati's Bingfang Yan, who recently received a a $2.5 million National Institutes of Health grant to study how COVID-19 therapeutics can work together to create more effective and safe treatments for patients.
March 21, 2023
A startup founded by four University of Cincinnati physicians has raised approximately $10 million in funding, including a recent $250,000 investment from St. Elizabeth Healthcare, the Cincinnati Business Courier reported.
March 21, 2023
Amanda Jackson, MD, is the site principal investigator at the University of Cincinnati for the UP-NEXT trial that is testing a new treatment for a subset of ovarian cancer patients.